1、November 2021Fuelling Further Growth of Biotech and Healthcare Industries:Leveraging Hong Kongs Financial InfrastructureFSDC Paper No.51ContentsExecutive SummaryBackground and Overview Global Landscape of Healthcare and Biotech Sectors Recent developments of the healthcare and biotech sectors Global

2、 capital market activities Comparison between the US,Mainland China and EUOpportunities and Challenges for Hong Kong Capitalising on the dynamic financial markets Embracing digitalisation in biotech and healthcare As a gateway to Mainland China Challenges facing the local community survey and interv

3、iew findingsPolicy Recommendations i)Financing ii)Commercialisation iii)TalentConclusionAppendix 1.Support available to healthcare and biotech sectors by Cyberport and Hong Kong Science and Technology ParkAppendix 2.Intellectual property financing opportunities and challengesAppendix 3.Survey findin

4、gs1489111319192020212326333842444650Executive SummaryIn recent years,governments around the world are putting increasing emphasis on healthcare-and biotechnology-related sectors,as longer life expectancy and better health conditions of citizens would not only mean a larger work force,but also enhanc

5、ed overall social well-being.Serving as a reminder of the importance of such sectors,the recent global pandemic is seemingly urging the society to invest further into research and development(R&D)of relevant work.With the United Nations estimating that the population aged 65 or above will reach 1.5

6、billion by 2050,nearly doubling that in 2020,1 both public and private sectors have been stepping up allocation of resources,including financial resources,to healthcare and biotechnology sectors.In this respect,Hong Kong as a capital formation centre has played an indispensable role in mobilising ca